Page last updated: 2024-10-25

clofibrate and Compensatory Hyperinsulinemia

clofibrate has been researched along with Compensatory Hyperinsulinemia in 2 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.

Research Excerpts

ExcerptRelevanceReference
"Metabolic syndrome is associated with increased cardiovascular risk."2.41[Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome]. ( Idzior-Waluś, B, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Idzior-Waluś, B1
Mabuchi, H1
Mibayashi, Y1
Ota, M1
Miyamoto, S1
Yamada, S1

Reviews

1 review available for clofibrate and Compensatory Hyperinsulinemia

ArticleYear
[Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome].
    Przeglad lekarski, 2001, Volume: 58, Issue:10

    Topics: Cardiovascular Diseases; Clofibrate; Fenofibrate; Hemostasis; Humans; Hyperinsulinism; Hyperlipidemi

2001

Other Studies

1 other study available for clofibrate and Compensatory Hyperinsulinemia

ArticleYear
[Metabolic anomaly of obesity: therapeutic results of combined diet and chemotherapy].
    Nihon rinsho. Japanese journal of clinical medicine, 1974, Volume: 32, Issue:3

    Topics: Adult; Clofibrate; Diet, Reducing; Female; Humans; Hyperinsulinism; Male; Middle Aged; Obesity

1974